# AbbVie Inc. – Consensus ‘buy’ rating and 14.1% Upside Potential

- Link: https://www.directorstalkinterviews.com/abbvie-inc-consensus-buy-rating-and-14-1-upside-potential/4121185457
- Published: 2025-01-31T12:37:03+00:00
- Author: Charlotte Edwards

**AbbVie Inc.** which can be found using ticker (ABBV) now have 27 market analysts
covering the stock. The analyst consensus now points to a rating of ‘buy’. The range
between the high target price and low target price is between $227.00 and $165.00
suggesting an average Analsyt target price of $199.97. Given that the stocks previous
close was at $175.26 this is indicating there is a potential upside of 14.1%. The
day 50 moving average is $175.25 while the 200 day moving average is $178.73. The
company has a market cap of 310.40B. Currently the stock stands at: $175.65 USD

 The potential market cap would be $354,160,681,955 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 61.42, revenue per share of $31.40
and a 7.72% return on assets.

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. 
The Company is engaged in the research and development, manufacturing, commercialization
and sale of medicines and therapies. It offers products in various therapeutic categories,
including immunology products, which include Humira, Skyrizi and Rinvoq; oncology
products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that
include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience
products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye
care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis,
and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella
and Synthroid. Its products are sold to wholesalers, distributors, government agencies,
health care facilities, specialty pharmacies, and independent retailers from the
AbbVie-owned distribution centers and public warehouses.

Share on:
